Vertex Pharmaceuticals Inc / Ma SEC filings VRTX
Vertex Pharmaceuticals Inc / Ma has 1,001 filings in SEC EDGAR's recent list, going back to Jun 3, 2020. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 20, 2026 | Oct 20, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 1, 2026 | Aug 27, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Jul 7, 2026 | Jul 6, 2026 |
| S-8 POS | Filing | May 13, 2026 | — |
| S-8 POS | Filing | May 13, 2026 | — |
| S-8 POS | Filing | May 13, 2026 | — |
| S-8 POS | Filing | May 13, 2026 | — |
| S-8 POS | Filing | May 13, 2026 | — |
| S-8 POS | Filing | May 13, 2026 | — |
| S-8 POS | Filing | May 13, 2026 | — |
| S-8 | Employee stock plan registration | May 13, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 13, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 4, 2026 | May 4, 2026 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Apr 29, 2026 | Apr 28, 2026 |
| UPLOAD | Letter from the SEC | Apr 14, 2026 | — |
| ARS | Annual report to shareholders | Apr 2, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 2, 2026 | — |
| DEF 14A | Proxy statement | Apr 2, 2026 | May 13, 2026 |
| CORRESP | Letter to the SEC | Apr 1, 2026 | — |
| 8-K |
Current report
Other events
|
Mar 31, 2026 | Mar 31, 2026 |
| UPLOAD | Letter from the SEC | Mar 18, 2026 | — |
| 10-K | Annual report | Feb 13, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2026 | Feb 12, 2026 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2025 | Nov 3, 2025 |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 4, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Other events
|
May 19, 2025 | May 19, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 14, 2025 | May 14, 2025 |
| UPLOAD | Letter from the SEC | May 7, 2025 | — |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 5, 2025 | May 5, 2025 |
| CORRESP | Letter to the SEC | May 5, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2025 | — |
| ARS | Annual report to shareholders | Apr 3, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 3, 2025 | — |
| DEF 14A | Proxy statement | Apr 3, 2025 | May 14, 2025 |
| 8-K |
Current report
Other events
|
Mar 28, 2025 | Mar 28, 2025 |
| S-3ASR | Automatic shelf registration | Feb 13, 2025 | — |
| 10-K | Annual report | Feb 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Feb 10, 2025 | Feb 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 20, 2024 | Dec 20, 2024 |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Material agreement
|
Aug 16, 2024 | Aug 15, 2024 |
| 10-Q | Quarterly report | Aug 2, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Other events
|
Jun 27, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Other events
|
May 20, 2024 | May 20, 2024 |
| SC TO-T/A | Filing | May 20, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2024 | May 15, 2024 |
| SC TO-T/A | Filing | May 10, 2024 | — |
| SC TO-T/A | Filing | May 8, 2024 | — |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 6, 2024 | May 6, 2024 |
| SC TO-T | Filing | Apr 22, 2024 | — |
| PX14A6G | Filing | Apr 16, 2024 | — |
| SC TO-C | Filing | Apr 11, 2024 | — |
| SC TO-C | Filing | Apr 11, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Apr 11, 2024 | Apr 10, 2024 |
| SC TO-C | Filing | Apr 10, 2024 | — |
| ARS | Annual report to shareholders | Apr 4, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 4, 2024 | — |
| DEF 14A | Proxy statement | Apr 4, 2024 | May 15, 2023 |
| 10-K | Annual report | Feb 15, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 5, 2024 | Feb 5, 2024 |
| 8-K |
Current report
Other events
|
Dec 8, 2023 | Dec 8, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 5, 2023 | Dec 5, 2023 |
| 10-Q | Quarterly report | Nov 7, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 5, 2023 | Oct 3, 2023 |
| 10-Q | Quarterly report | Aug 2, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2023 | Aug 1, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 18, 2023 | May 17, 2023 |
| 10-Q | Quarterly report | May 2, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 1, 2023 | May 1, 2023 |
| ARS | Annual report to shareholders | Apr 6, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 6, 2023 | — |
| DEF 14A | Proxy statement | Apr 6, 2023 | — |
| 10-K | Annual report | Feb 10, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 7, 2023 | Feb 7, 2023 |
| 10-Q | Quarterly report | Oct 28, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Oct 27, 2022 | Oct 27, 2022 |
| UPLOAD | Letter from the SEC | Oct 4, 2022 | — |
| CORRESP | Letter to the SEC | Sep 26, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2022 | — |
| S-8 | Employee stock plan registration | Aug 5, 2022 | — |
| 10-Q | Quarterly report | Aug 5, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Other events
|
Jul 11, 2022 | Jul 9, 2022 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Jul 5, 2022 | Jul 1, 2022 |
| 8-K |
Current report
Other events
|
May 23, 2022 | May 23, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 18, 2022 | May 18, 2022 |
| 10-Q | Quarterly report | May 6, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 5, 2022 | May 5, 2022 |
| DEFA14A | Additional proxy material | Apr 7, 2022 | — |
| DEF 14A | Proxy statement | Apr 7, 2022 | May 18, 2022 |
| S-3ASR | Automatic shelf registration | Feb 9, 2022 | — |
| 10-K | Annual report | Feb 9, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Jan 26, 2022 | Jan 26, 2022 |
| 10-Q | Quarterly report | Nov 3, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2021 | Nov 2, 2021 |
| 10-Q | Quarterly report | Jul 30, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2021 | Jul 29, 2021 |
| 8-K |
Current report
Other events
|
Jun 24, 2021 | Jun 23, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2021 | May 19, 2021 |
| 10-Q | Quarterly report | Apr 30, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2021 | Apr 29, 2021 |
| PX14A6G | Filing | Apr 29, 2021 | — |
| 8-K |
Current report
Material agreement
|
Apr 20, 2021 | Apr 16, 2021 |
| DEFA14A | Additional proxy material | Apr 8, 2021 | — |
| DEF 14A | Proxy statement | Apr 8, 2021 | May 19, 2021 |
| 10-K | Annual report | Feb 11, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 1, 2021 | Feb 1, 2021 |
| 8-K |
Current report
Other events
|
Nov 20, 2020 | Nov 20, 2020 |
| 10-Q | Quarterly report | Oct 30, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2020 | Oct 29, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 21, 2020 | Sep 18, 2020 |
| 10-Q | Quarterly report | Jul 31, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2020 | Jul 30, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2020 | Jun 3, 2020 |
Showing 127 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VRTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MA
- Headquarters
- Boston, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 875320
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.